Daniel W Lee

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson et al. · The Lancet · 2014 · 2.9K citations

Life Sciences, Hematology, Oncology +17

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

Terry J. Fry, Nirali N. Shah, Rimas J. Orentas et al. · Nature Medicine · 2017 · 1.3K citations

Life Sciences, Immunology, Oncology +14

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Marcela V. Maus, S. Alexander, Michael R. Bishop et al. · Journal for ImmunoTherapy of Cancer · 2020 · 269 citations · Full text

Life Sciences, Immunology, Oncology +17

Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies

Haneen Shalabi, Vandana Sachdev, Amita Kulshreshtha et al. · Journal for ImmunoTherapy of Cancer · 2020 · 100 citations · Full text

Medicine, Hematology, Oncology +17

Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation

Elizabeth M. Holland, John C. Molina, Kniya DéDé et al. · Journal for ImmunoTherapy of Cancer · 2022 · 56 citations · Full text

Medicine, Hematology, Oncology +17